In plain terms: Whole Body Vibration shows early signals in human research but the evidence is limited -- small trials, surrogate endpoints, or not yet independently replicated. It is an emerging area, not yet a proven one.
Whole Body Vibration
The evidence as the record states it
Slatkovska et al. (Annals of Internal Medicine, 2011; PMID 22084333): 202 postmenopausal women with low bone density, 20 minutes a day of vibration at 90 Hz or 30 Hz or no vibration for 12 months, assessors blinded: no effect on any bone outcome at the hip or spine. Kiel et al. (Journal of Bone and Mineral Research, 2015; PMID 25581217), VIBES: 174 adults with a mean age of 82, active or placebo platform for 24 months: no difference in hip or spine bone density or bone turnover markers. Jepsen et al. (BMJ Open, 2017; PMID 29289937), 14 trials: no overall effect on bone density. Harijanto et al. (Gerontology, 2022; PMID 34781288): no significant effect at the hip or lumbar spine. Massini et al. (PeerJ, 2025; PMID 40391029): a small effect at the total femur only. Chen et al. (BMC Musculoskeletal Disorders, 2026; PMID 41559705), 14 trials, 1,447 participants: gains at some hip sites and L2 to L4, none at L1 to L4 or the total hip, and 79% of trials at some risk of bias. de Oliveira et al. (Osteoporosis International, 2023; PMID 36282343): lumbar spine gains only in subgroups using particular settings. Mixed results with null large trials: Grade C.
Why Grade C and not Grade B
Grade C reflects early or limited human evidence -- small trials, surrogate endpoints, or preliminary findings not yet independently replicated. The evidence points in a promising direction but does not yet meet the standard for Grade B. A single well-powered, independently replicated trial with a meaningful endpoint would move this to Grade B or higher.
What this grade covers and what it does not
What would move this grade
A well-powered randomized trial with an objective, clinically meaningful primary endpoint and at least one independent replication would support Grade B or higher.
How this was studied
Form: Vertical whole-body vibration platforms, standing or doing squats and heel raises on the platform, against conventional exercise, light exercise, a placebo platform or no intervention (Chen 2026, PMID 41559705; Slatkovska 2011, PMID 22084333; Kiel 2015, PMID 25581217). · Dose: 12.6 to 45 Hz, 0.5 to 12 mm amplitude, 10 to 60 minutes, 2 to 5 sessions a week across the pooled trials (Chen 2026, PMID 41559705); 0.3 g at 90 Hz or 30 Hz for 20 minutes a day (Slatkovska 2011, PMID 22084333). · Population: 1,447 adults aged 60 to 93, 96% women (Chen 2026, PMID 41559705); 202 postmenopausal women with low bone density (Slatkovska 2011, PMID 22084333); 174 adults with a mean age of 82 (Kiel 2015, PMID 25581217). · Duration: 8 to 72 weeks in the pooled trials (Chen 2026, PMID 41559705); 12 months (Slatkovska 2011, PMID 22084333); 24 months (Kiel 2015, PMID 25581217).